These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8872064

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beta 2-microglobulin does not behave as a biological marker of bone remodeling in patients with primary hyperparathyroidism.
    Broulik PD, Stepán JJ, Haas T.
    Clin Chim Acta; 1998 Nov; 278(1):61-6. PubMed ID: 9877125
    [Abstract] [Full Text] [Related]

  • 8. beta 2-Microglobulin in Paget's bone disease.
    Rico H, Ripoll E, Arribas I, Revilla M, Relea P, Villa LF, de Buergo MA.
    Calcif Tissue Int; 1994 May; 54(5):389-91. PubMed ID: 8062156
    [Abstract] [Full Text] [Related]

  • 9. Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis.
    Wu Q, Zhong ZM, Pan Y, Zeng JH, Zheng S, Zhu SY, Chen JT.
    Med Sci Monit; 2015 Aug 18; 21():2428-32. PubMed ID: 26286507
    [Abstract] [Full Text] [Related]

  • 10. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J, Małyszko JS, Pawlak K, Wołczyński S, Myśliwiec M.
    Adv Med Sci; 2006 Aug 18; 51():69-72. PubMed ID: 17357281
    [Abstract] [Full Text] [Related]

  • 11. Can a determination of tartrate-resistant acid phosphatase predict postmenopausal loss of bone mass?
    Rico H, Arribas I, Villa LF, Casanova FJ, Hernández ER, Cortés-Prieto J.
    Eur J Clin Invest; 2002 Apr 18; 32(4):274-8. PubMed ID: 11952813
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 15. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
    Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Väänänen HK.
    J Bone Miner Res; 2000 Jul 01; 15(7):1337-45. PubMed ID: 10893682
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cortical bone resorption in osteoporosis.
    Aguado F, Revilla M, Villa LF, Rico H.
    Calcif Tissue Int; 1997 Apr 01; 60(4):323-6. PubMed ID: 9075626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of ipriflavone on postmenopausal syndrome and osteoporosis.
    Zhang X, Li SW, Wu JF, Dong CL, Zheng CX, Zhang YP, Du J.
    Gynecol Endocrinol; 2010 Feb 01; 26(2):76-80. PubMed ID: 19672742
    [Abstract] [Full Text] [Related]

  • 20. Circulating biochemical markers of bone remodeling in uremic patients.
    Ureña P, De Vernejoul MC.
    Kidney Int; 1999 Jun 01; 55(6):2141-56. PubMed ID: 10354264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.